Announcements Trials
Browse Landscape

Phase

Phase 1 37Phase 2 28Phase NA 14Phase 3 11Phase 1/2 3Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 29Thoracic 26Head & Neck 22Gynecologic 15Breast 13Genitourinary 11Dermatologic 8Sarcoma 5NET 4Endocrine 4Tumor-Agnostic 3Other solid neoplasm 2Lymphoid 2Plasma cell 1

Conditions

Neoplasms 172Neoplasm Metastasis 66Adenocarcinoma 13Carcinoma, Squamous Cell 7Carcinoma 3Neoplasms by Site 2Neoplasms, Unknown Primary 1Neoplasms, Second Primary 1

Interventions

Trastuzumab 1ProMune 1Panitumumab 1Chemoradiotherapy 1AEG 35156 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Carcinoma × Tumor-Agnostic × Clear all
NCT01581840 2024-07-01

Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus

Federation Francophone de Cancerologie Digestive

Phase 1/2 Completed
45 enrolled 12 charts
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT00031278 2011-05-30

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Pfizer

Phase 1/2 Completed
12 enrolled
Tumor-Agnostic

Carcinoma, Neoplasm Metastasis, Neoplasms

NCT00557596 2009-12-01

A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer

Aegera Therapeutics

Phase 1/2 Terminated
48 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡